Q2 Solutions vaccine laboratory services are supported by global, comprehensive central laboratory services to meet your development needs across the entire vaccine development life cycle. Learn more
Download a copy of our presentations.
In vivo model design and assay selection to aid in progression from preclinical to clinical
Isabelle Meunier
Associate Principal Scientist, Assay Development
Considerations to select optimal functional assay for comprehensive vaccine efficacy data
Steven Phay Tran
Director of CMI & LBA
DOWNLOAD PRESENTATION
The outbreak of the SARS-CoV-2 virus caused a sudden shift in focus for the biopharmaceutical industry. After the genetic sequence of the virus was released in early 2020, vaccine manufacturers across the globe began the race to research and develop vaccines to combat the virus... Read more
Originally posted on Nexelis.com on 25May2022
When efforts to fight the emerging COVID-19 pandemic began in January 2020, there was little data available for research and development teams to work with as they began developing a response to the virus... Read more
Originally posted on Nexelis.com on 22June2022